FARALLON CAPITAL MANAGEMENT LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$15,502,000
-0.2%
350,0000.0%0.06%
-18.2%
Q1 2021$15,530,000
+41.6%
350,000
+75.0%
0.08%
+16.7%
Q4 2020$10,968,000
+36.1%
200,000
-43.5%
0.07%
+22.2%
Q4 2019$8,059,000354,0820.05%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
M28 Capital Management LP 665,880$10,627,00011.09%
RTW INVESTMENTS, LP 15,802,802$252,213,0005.82%
Ally Bridge Group (NY) LLC 479,506$7,653,0005.05%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,204,0002.48%
TIGER MANAGEMENT L.L.C. 279,700$4,464,0001.95%
Prosight Management, LP 200,000$3,192,0001.71%
COWEN AND COMPANY, LLC 999,588$15,953,0001.53%
Boxer Capital, LLC 1,466,051$23,398,0001.32%
Affinity Asset Advisors, LLC 267,794$4,274,0001.19%
HARBOR CAPITAL ADVISORS, INC. 66,410$1,060,0000.97%
View complete list of ROCKET PHARMACEUTICALS INC shareholders